The Insulin-like Growth Factor I Receptor/Insulin Receptor Tyrosine Kinase Inhibitor PQIP Exhibits Enhanced Antitumor Effects in Combination with Chemotherapy Against Colorectal Cancer ModelsSara A. Flanigan, Stephen Leong|Clinical Cancer Research|2010Cited by 44